Abstract:A panel of experts recently completed updating the European Guidelines for the use of Ultrasound Contrast Agents. It is due to be published in early 2008 and updates and extends the 2004 Guidelines, which covered only the liver. The new liver section, which includes the use of USCM in interstitial ablation, incorporates the recent Barcelona guidelines for management of focal lesions discovered during ultrasound surveillance in cirrhotic patients. Though focussed on SonoVue, it forms a useful framework for a general discussion of this topic. It also covers clinically established uses in the kidneys and pancreas, in abdominal trauma, in vesico-ureteric reflux and in transcranial studies. The liver section of the guidelines opens with a rationale for beginning with characterisation of focal lesions rather than their detection, as may seem logical. This points up a fundamental awkwardness of the way USCM work in the liver: the initial arterial phase is particularly useful for differentiating between various focal lesions, while the late (sinusoidal) phase is critical for determining the malignant nature of solid liver lesions. Benign lesions such as haemangiomas and focal nodular hyperplasia have a rich arterial supply and often enhance early in the arterial phase. In haemangiomas, the blood enters the lakes that constitute the abnormality at the periphery of the lesion, giving rise to peripheral nodular enhancement. From here, it percolates towards the centre of the haemangioma, usually fairly slowly, taking up to five minutes to fill completely. At this stage, the lesion disappears as it matches the intensity of the enhanced liver parenchyma, though the process is incomplete in haemangiomas that contain thrombus, usually larger lesions. Thus, delayed scanning is required to confirm that the lesion has disappeared or at least become smaller. FNHs also have an arterial supply via one or several tortuous feeding vessels. However, the flow pattern is distinctive, arriving first at the centre of the lesion and filing it in a centrifugal fashion, often forming a spoke wheel pattern. The enhancement is often intense and very rapid (the “light bulb sign”) and so the early images after arrival of the contrast are critical; the study should be recorded so that these early frames can be reviewed, if necessary in slow motion, to allow the characteristic pattern to be recognised. In the late phase, FNHs disappear as the liver enhancement matches the enhancement in the lesion. In around a quarter of cases, the central scar becomes visible in this phase as a stellate central filling defect. For both lesions, these features carry the same confidence as the equivalent CT or MR haemodynamic findings and do not require further investigation when they are typical, as is the case in around 75% of cases. Atypical cases, which amount to 5 or 10%, require further investigation. Other lesions with diagnostic haemodynamic patterns are focal fatty sparing and change as well as regenerating nodules: they have normal haemodynamics and so behave in exactly the same way as the surrounding liver, disappearing in the late phase. Hepatic adenomas seem to have a variety of patterns, but experience with them is still limited, as it is for other uncommon focal lesions such as granulomas and peliosis.

Preoperative Diagnosis for Space Occupying Lesion of the Liver

Comparative the Clinical Value of Contrast-Enhanced Ultrasonography, Enhancement CT and MRI for Diagnosing of Liver Lesions.

Diagnosis and Treatment of Rare Types of Hepatic Benign Space Occupying Lesions

Space Occupying Lesion of the Spleen

Diagnostic Value and Clinical Significance of Whole Body PET/CT and Localized PET/MR Combined Imaging for Liver Space Occupying Lesions

Application of Contrast-Enhanced Sonography for Diagnosis of Space-Occupying Lesions in the Extrahepatic Bile Duct: Comparison With Conventional Sonography and Contrast-Enhanced Computed Tomography.

[Clinical application of precise liver resection techniques in patients with complicated liver space-occupying lesions]

Correlation of imageological findings and pathological results of hepatocellular carcinoma

The Value of Contrast-Enhanced Ultrasound Guided Biopsy in Hepatic Space-Occupying Lesions

Preliminary application of dynamic three-dimensional contrast-enhanced ultrasonography in diagnosis of liver tumor

Comparison and correlation of CT scan and MRI for focal liver lesion detection and characterization

Characterization of focal liver lesions: comparison of MRI and MSCT

Rare type of hepatic benign tumor and tumor-like lesions

Value of Delayed-Phase Dynamic CT Enhancement in Preoperative Evaluation for Focal Liver Lesions

The Diagnosis of 18 F-fluorodexoxyglucose and 11C-Acetate PET/CT Scanning in Primary Liver Tumors and Tumor-Like Diseases : a Preliminary Study

Preoperative imaging evaluation for resectable colorectal liver metastasis

Imaging of Focal Liver Lesions

Triphasic dynamic contrast-enhanced computed tomography predictive model of benign and malignant risk of gallbladder occupying lesions

- 32S 2-1 9 th US Contrast The Diagnosis of Liver Tumours with Ultrasound Contrast

Study of Clinical Application of Hepatic-Biliary Specific MR Contrast Agent(gd-Eob-dtpa) in the Diagnosis of Focal Hepatic Lesions

Diagnosis and Survival Analyses of Patients with Space-Occupying Cardiac Lesions: a 10-Year Retrospective Single-Center Study